BIG PHAMA IS TARGETING SENIORS IN A SHOCKING NEW CASH GRAB, as Novo Nordisk CEO Mike Doustdar revealed a plan to capture 15 MILLION new elderly patients the moment Medicare starts bankrolling their controversial obesity drugs. This isn’t about health—it’s a calculated invasion of America’s retirement funds, backed by a DEAL STRUCK WITH DONALD TRUMP himself.
The chilling admission exposes a corporate strategy to monetize the aging population, with executives salivating over a government-sanctioned windfall. While health experts warn of a tidal wave of new prescriptions, Doustdar COLDY ADMITS the rollout will be slow, proving this is about long-term profit, NOT urgent patient care. Meanwhile, rival Eli Lilly is already boasting, revealing a cutthroat race to dominate a market now FUNDED BY TAXPAYERS.
Behind the sanitized corporate speak lies a BRUTAL MARKET WAR. Novo is LOSING, hemorrhaging market share to Lilly and desperate to claw it back with a new pill and higher doses. The CEO’s supposed “hope” for patient choice is a thinly veiled threat: a corporate arms race where seniors are the battlefield and their health is the collateral.
This is the future Big Pharma bought: where politicians broker deals, CEOs target vulnerable millions, and your retirement security is repackaged as quarterly earnings. The American body is no longer a temple—it’s a revenue stream, and they’re coming for everyone, from the Oval Office to your medicine cabinet.
Author: Kayitsi.com
